Literature DB >> 7510706

Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases.

D M Milne1, D G Campbell, F B Caudwell, D W Meek.   

Abstract

The p53 tumor suppressor protein is tightly regulated in the cell and is phosphorylated at multiple sites by several different protein kinases. We have investigated the phosphorylation of p53 by mitogen-activated protein (MAP) kinase, a protein kinase that plays a central role in mediating many mitogenic and differentiation signals. Recombinant wild-type mouse p53 was phosphorylated in vitro by activated recombinant p42-MAP kinase but not by inactive MAP kinase or by the activating protein, MAP kinase kinase. Phosphorylation of p53 by MAP kinase occurred at two N-terminal sites, threonine residues 73 and 83. Tryptic phosphopeptides of recombinant p53 phosphorylated in vitro by MAP kinase comigrated on two-dimensional maps with p53 from SV3T3 cells labeled in vivo with [32P]orthophosphate, suggesting that MAP kinase targets a site in p53 that is phosphorylated in the cell. Following serum stimulation of quiescent C57MG cells, two p53 kinases, which were resolved by chromatography on Mono Q, were stimulated 15-20-fold within 5 min. Each of these kinase activities co-eluted with myelin basic protein kinase activity and could be inactivated following treatment with protein phosphatase 2A, a serine/threonine phosphatase, or leukocyte antigen receptor, a protein tyrosine phosphatase, suggesting that these activities were members of the MAP kinase family. The two kinase activities from the lysates targeted the same phosphorylation sites on p53 as the purified recombinant MAP kinase. These protein kinase activities were also stimulated following exposure of the cells to ultraviolet radiation, but with slightly delayed kinetics. Phorbol ester treatment of SV3T3 cells led to increased phosphorylation of the peptide containing the residues targeted by MAP kinase. The data suggest that p53 may be phosphorylated by MAP kinase physiologically and that this interaction may be involved in the cell's response to UV exposure, growth factor stimulation, or transformation by oncogenes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510706

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

2.  Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.

Authors:  L McKendrick; D Milne; D Meek
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

Review 3.  Cell apoptosis induced by carcinogenic metals.

Authors:  F Chen; V Vallyathan; V Castranova; X Shi
Journal:  Mol Cell Biochem       Date:  2001-06       Impact factor: 3.396

4.  Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest.

Authors:  Drew Burdon; Rajnikant Patel; R A John Challiss; Jonathan L Blank
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

5.  Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase.

Authors:  Chun-Jen Chen; Kazuo Sugiyama; Hideyuki Kubo; Cheng Huang; Shinji Makino
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro.

Authors:  H Lu; R P Fisher; P Bailey; A J Levine
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

7.  Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells.

Authors:  Dae-Hee Lee; Clifford Kim; Lin Zhang; Yong J Lee
Journal:  Biochem Pharmacol       Date:  2008-02-29       Impact factor: 5.858

Review 8.  The role of alphav integrins during angiogenesis.

Authors:  B P Eliceiri; D A Cheresh
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

9.  Pharmacoproteomic analysis of a novel cell-permeable peptide inhibitor of tumor-induced angiogenesis.

Authors:  Ji-Young Bang; Eung-Yoon Kim; Dong-Ku Kang; Soo-Ik Chang; Moon-Hi Han; Kwang-Hyun Baek; In-Cheol Kang
Journal:  Mol Cell Proteomics       Date:  2011-05-10       Impact factor: 5.911

Review 10.  Regulation of p53 by protein kinase C during multi-stage carcinogenesis.

Authors:  L Magnelli; V Chiarugi
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.